Melissa B. Cummings - 02 Mar 2026 Form 4 Insider Report for Progyny, Inc. (PGNY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Mar 2026, 17:32:14 UTC
Prior SEC filing
02 May 2025
Next SEC filing
16 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Livingston, Attorney-in-Fact

Key filing fact

Melissa B. Cummings filed Form 4 for Progyny, Inc. (PGNY) on 04 Mar 2026.

Key facts

  • This page summarizes Melissa B. Cummings's Form 4 filing for Progyny, Inc. (PGNY).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Mar 2026, 17:32.

Change

  • Previous filing in this sequence was filed on 02 May 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002066495 Primary reporting owner

Cummings Melissa B

Relationship
Chief Operating Officer
Address
C/O PROGYNY, INC., 1359 BROADWAY, 2ND FL, NEW YORK
Signature
/s/ Mark Livingston, Attorney-in-Fact
Signature date
04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Award

Transaction value
Shares
+45,454
Change %
+109%
Price
$0.000000*
Shares after
87,121
Date
02 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+66,289
Change %
Price
$0.000000*
Shares after
66,289
Date
02 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
66,289
Exercise price
$17.60
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). This was an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. 33% of the RSUs will vest on the first anniversary of the grant date, with the remainder vesting quarterly in installments thereafter through the third anniversary of the grant date, subject to the Reporting Person's continued service on each applicable vesting date.

Footnote F2

Represents an annual merit grant made pursuant to the Issuer's 2019 Equity Incentive Plan. 33% of the shares will vest on the first anniversary of the grant date, with the remainder vesting quarterly in installments thereafter through the third anniversary of the grant date, subject to the Reporting Person's continued service on each applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .